Qysmia’s adverse effects on cognition

Posted on Thursday, November 20th, 2014 at 1:36 pm    

Qysmia is a newly-approved weight-loss medicine that contains two active ingredients: appetite suppressant Phentermine and the anticonvulsant drug Topiramate. Together, the two drugs work hand-in-hand to create a feeling of increased satiety and decreased appetite.

Over the years, however, Qysmia has been associated with cases of compromised cognitive processes among individuals who took it. Some researchers believe Qysmia’s cognitive effects are caused by Topiramate. In a 2010 study published by the Journal of Neurology, Neurosurgery, and Psychiatry, scientists found out that using Topiramate may decrease verbal IQ, verbal fluency, and verbal learning, while withdrawing or reducing its dose resulted in improvements.

But although Qymsia’s cognitive effects could be reversible, one-year controlled trials of the drug revealed a number of patients still experienced effects, some of longer duration, even after Qysmia treatment. If you have been suffering from any cognitive disorder while or after taking Qysmia, consult with an attorney at Williams Kherkher to learn which legal steps are available in seeking justice and compensation. Call us at (800) 220-9341 today.

Surviving ovarian cancer

Posted on Thursday, November 20th, 2014 at 1:24 pm    

Ovarian cancer occurs when malignant cells develop and multiply in one or both ovaries. Considered the 5th deadliest cancer among women, ovarian cancer usually affects women aged 55 to 64 years old. Furthermore, some cases of ovarian cancer have been associated with women’s use of talc-based powders on their genitals.

Through its Surveillance, Epidemiology, and End Result (SEER) program, the National Cancer Institute found that women battling against ovarian cancer had a 44.6% chance of survival within the first five years. With early detection, proper medical care, and a shift to a healthier lifestyle, women with ovarian cancer may successfully win over this dreaded disease.

If you believe your cancer has resulted from using talcum powder products, our team of product liability attorneys at Williams Kherkher can assess your situation for free. Call us now at (800) 220-9341 if you are considering filing a legal claim against the manufacturers responsible.

The dangers of pancreatitis

Posted on Thursday, November 20th, 2014 at 1:10 pm    

Pancreatitis, or the inflammation of the pancreas, happens when the digestive enzymes inside your pancreas become activated before being released into the small intestine to aid in digestion. The activated enzymes will then irritate the cells and the tissues of the pancreas, causing the organ to be inflamed.

If pancreatitis is left untreated, serious medical complications may occur. These may include:

  • Infection – The inflamed organ makes it vulnerable to infectious agents
  • Pancreatic cancer – Persistent pancreatitis is considered one of pancreatic cancer’s risk factors
  • Diabetes – Disorders of the pancreas may result in a compromised production of insulin, a hormone important in regulating the levels of sugar in the blood
  • Malnutrition – Pancreatitis may lead to lower production of pancreatic juice necessary in digesting fats, proteins and carbohydrates

Unfortunately, the risk of pancreatitis is higher among individuals who are taking the anti-psychotic drug Risperdal. If taking this drug has compromised your health in any way, learn about your options to file a lawsuit against the manufacturer involved. Consult with an attorney at Williams Kherkher by calling 800-220-9341 today.

Further investigation into La Porte DuPont plant reveals multiple violations

Posted on Wednesday, November 19th, 2014 at 2:53 pm    

Over the weekend, a chemical leak at a DuPont plant killed four workers. While the plant had been cited previously for safety violations, federal inspectors hadn’t inspected the facility since 2007. The 2007 inspection, performed by inspectors from the Occupational Safety and Health Administration (OSHA), cited four serious safety violations, including violations of safe management for hazardous chemicals.

In the chemical leak this past weekend, an estimated 100 pounds of methyl mercaptan leaked throughout the plant. Unfortunately, even the smallest amount of exposure can be fatal. It has since been discovered that this toxic chemical leak was caused by a faulty valve.

The Environmental Protection Agency (EPA) also brought formal enforcement actions against the DuPont plant for 2012 and 2014 violations that cost the plant $117,375 in penalties.

DuPont stated that they are taking steps to make sure the area is safe to access. With regards to the multiple safety violations, DuPont states they “are committed to meeting or exceeding all applicable state and federal regulatory requirements.”

Medications that can increase bleeding risks of people taking Xarelto

Posted on Wednesday, November 19th, 2014 at 10:25 am    

Patients taking Xarelto have an increased risk of serious bleeding that can be fatal, especially when combined with other medicines, including the following:

• Warfarin sodium drugs like Jantoven and Coumadin
• Any medicine containing aspirin or heparin
• Non-steroidal anti-inflammatory drugs
• Medicines that contain “Clopidogrel” to inhibit blood clots

Patients planning to take Xarelto are advised to tell their physician if they are taking any of the medications mentioned above or any other medications that they are currently using. Be sure to also inform your physician of any existing bleeding related conditions.

Unfortunately some Xarelto users suffer serious prolonged and uncontrollable gastrointestinal bleeding. If you or someone you know taking Xarelto has experienced this, treatment funds may be awarded to you to recover your loss. Consult with us today about your situation with the legal team of Williams Kherkher at (800) 220-9341 to find out how we may help you pursue claims against negligent drug makers.

How Benicar helps reduce high blood pressure

Posted on Wednesday, November 19th, 2014 at 10:07 am    

Benicar reduces the risk of complications from high blood pressure by introducing the active ingredient “olmesartan” into the body.

Benicar and its counterpart, hydrochlorothiazide (HCT), both work to obstruct the naturally occurring chemical angiotensin II, which is partially responsible for increasing blood pressure. Blocking this chemical relaxes and widens the blood vessels. Benicar HCT additionally reduces the body’s water content that can also cause blood pressure to increase. Clinical studies revealed that patients taking this medication will decrease their blood pressure for 24 hours, and if taken regularly as prescribed by doctors it will continue reduce blood pressure for up to one year.

Though Benicar works to decrease the chance of cardiovascular problems in patients by reducing high blood pressure, serious or even fatal intestinal side effects can occur. If you or a loved one have experienced this, the legal team of Williams Kherkher may help you figure out if you are entitled to receive remunerations for your treatment. Call our office today at (800) 220-9341 to find out how we may help you seek compensation from using this potentially hazardous drug.

Promising new melanoma treatment drug – University of Colorado study

Posted on Wednesday, November 19th, 2014 at 9:16 am    

A University of Colorado Cancer Study Center study that was recently published in the journal Molecular Cancer Therapeutics showed that a new melanoma drug, the experimental TAK-733, has been successful in generating anti-cancer activity in 10 out of 11 mice treated with it, Drug Discovery and Development reported on November 12.

CU School of Medicine associate professor and CU Cancer Center investigator John Tentler, PhD, gave further credibility to the study by noting that patient-derived xenographs were used, meaning the melanoma samples given to the mice were from human patients affected by the disease. This has been prove to give a more accurate reading on how well drugs will work on humans.

There are around 1 million people in the United States who are currently suffering from melanoma, statistics from the National Cancer Institute showed.

Melanoma cell invasion has been purported to be brought about by the use of the male fertility drug Viagra. If you should develop this illness and you attribute it to your Viagra use, get in touch with our attorneys at Williams Kherkher to gain legal assistance by dialing 800-220-9341 today.

Shame and silence plagues those with hypospadias

Posted on Tuesday, November 18th, 2014 at 2:55 pm    

Mail Online discusses the emotional toll that is often a result for those diagnosed with hypospadias.

Hypospadias is a birth defect where the urethral opening is at an abnormal spot. Some men interviewed said they feel alone and isolated, despite the relative prevalence of this disorder (affecting one out of every 300 men)  due to the reluctance of many to discuss their condition. Data of pediatric urological surgeons revealed that from 1999 up to 2010, 14.5 percent children with hypospadias have undergone a minimum of three surgeries to attempt to correct the defect. James Newman, who has undergone 19 surgical procedures to correct his hypospadias, suffered complications and eventually developed post-traumatic stress disorder. Though surgery is a common option, some are now advocating for a non-surgical option.

The incidence of hypospadias is growing; this may be due to exposure to defective pharmaceuticals like Topamax in the womb. The lawyers of Williams Kherkher know that many men suffer physical and emotional consequences from hypospadias. Discuss your case with us today in confidence at (800) 220-9341 to see if we may be able to hold negligent parties responsible.

4 killed in chemical leak at DuPont plant in La Porte

Posted on Sunday, November 16th, 2014 at 4:54 pm    

Four workers were killed at a DuPont chemical plant in La Porte, Texas, on Saturday, November 15, after an early morning chemical leak. According to reports, a leak of methyl mercaptan was reported at around 4:00 am CST at the plant, located less than 30 miles outside of Houston. In addition to the four reported fatalities, another worker was taken to the hospital and is expected to recover from complications related to exposure to the chemical. Authorities say that the leak poses no danger to those living near the plant.

The gas leak was stopped at around 6:00 am, but the initial cause of the leak is still unknown at this time. We will continue to monitor the situation and provide updates as more information becomes available.


Two awarded cases against Topamax appealed in PA

Posted on Friday, November 7th, 2014 at 12:20 pm    

The two multi-million awarded cases of mothers whose babies sustained birth defects after ingesting Topamax were recently appealed in a Pennsylvania Superior Court, The Legal Intelligencer reported on October 29.

According to a Pennsylvania-based attorney, the claims of the two mothers who used Topamax were strong, and Janssen’s decision to appeal may affect their defense. The drug maker argued that compliance with federal regulators to label Topamax as “Category C” pregnancy drug and changing its classification may not be allowed by federal regulators. In the case of Haley Powell who was awarded $11 million last November, Janssen argued that Powell was not properly informed by her prescribing doctor about the possible side effects, and the U.S. Food and Drug Administration (FDA) prevented them from giving further warning to patients. Another plaintiff, April Czimmer, also received $4 million in October 2013. The two awarded cases were among the three bellwether claims against Topamax.

The lawyers at Williams Kherkher believe that many mothers are still out there whose babies are injured as a result of taking Topamax. If you are in such difficult situation, we may possibly help you get the funds to recover your loss. Find out how we may work for you today by calling 800-220-9341.

1 2 3 39

Williams Kherkher   |   8441 Gulf Fwy #600   |   Houston, TX 77017   |   Phone: (713) 230-2200   |   Toll Free: (800) 220-9341   |   Directions   |